Tag Archives: agn

Pfizer, Allergan Seal $160 Billion Tax-Inversion Deal

Big pharma Pfizer (PFE) fulfilled weeks of rumors Monday as it announced that it’s acquiring specialty-drug giant Allergan (AGN) in an all-stock deal valued at $160 billion. Pfizer agreed to provide Allergan shareholders with 11.3 Pfizer shares for each Allergan share, which based on Friday’s closing price values Allergan at $363.63 a share. This was somewhat lower than last week’s anonymously sourced press reports pegging the price at $370 to

Pfizer, Allergan Set To Unveil $150 Billion Inversion

Pfizer (PFE) will announce a takeover Monday morning to buy Botox maker Allergan (AGN) for more than $150 billion, according to multiple reports. That would make it the biggest tax inversion deal in history. Pfizer’s board signed off the deal Sunday, reports said, with a Monday announcement planned. Pfizer will pay 11.3 shares plus a small cash component for each share of Allergan. The stock element alone would be worth $363.63 per share. Reports

Tax-Inversion Rules Don’t Kill Pfizer-Allergan Hopes

Shares of drug giants Pfizer (PFE) and Allergan (AGN) were both up Friday as analysts said new U.S. Treasury guidelines on tax-inversion deals shouldn’t hinder the two companies’ possible merger. New York-based Pfizer has been in talks with Ireland-based Allergan since late last month about the possibility of a buyout that would allow Pfizer to relocate to Allergan’s lower-tax home. Wall Street generally approved of the idea, but on Thursday both